Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drugs Organometallic

Hartinger, C. G., Metzler-Nolte, N. Dyson, P. J. Challenges and Opportunities in the Development of Organometallic Anticancer Drugs. Organometallics 31, 5677-5685 (2012). [Pg.6]

Preparation of an analgesic drug Organometallic chemistry Palladium-catalyzed reaction Advanced laboratory experiment... [Pg.534]

Hormones and other endocrine disrupting compounds Illicit drugs and their human metabolic byproducts Organometallics... [Pg.200]

A major point that needs to be addressed in future work is the targeted delivery of organometallic anticancer drugs to cancer cells only. Also, additional features that generate cytotoxic activity other than disruption of DNA replication, such as the inclusion of molecular fragments that can interfere in cancer cell-specific cellular pathways, could be explored (11,103). [Pg.51]

The application of organometallic complexes of the other group 8 elements, iron and osmium, in anticancer drug design has until recently been almost exclusively focused on iron, with the ferrocenyl derivative of tamoxifen (ferrocifen) being the most prominent example (104). Organometallic osmium compounds have been little explored in this respect. [Pg.51]

Nonorganic and organometallic catalysts are also used to channel the reactions toward the chiral synthesis pathway. The drug called levodopa, (5)-3,4-dihydroxyalanine, is an effective drug against Parkinson s disease. It is stereoselectively manufactured using catalysts such as rhodium or ruthenium complexes. [Pg.338]

Combinatorial chemistry and solid-phase synthesis have evolved in the last decade to become one of the most important techniques to save time for drug discovery. To reach its full potential, the solid-phase synthesis has to incorporate many versatile organometallic reactions developed over recent several decades. The first example of the Nicholas reaction on solid phase was reported by Kann and his co-workers in 2002, which involves the reaction of polymer-bound cobalt complexes 51 with various carbon-centered nucleophiles in the presence of a Lewis acid to... [Pg.133]


See other pages where Drugs Organometallic is mentioned: [Pg.186]    [Pg.186]    [Pg.100]    [Pg.223]    [Pg.781]    [Pg.309]    [Pg.105]    [Pg.5]    [Pg.3]    [Pg.163]    [Pg.293]    [Pg.42]    [Pg.810]    [Pg.124]    [Pg.143]    [Pg.21]    [Pg.23]    [Pg.29]    [Pg.37]    [Pg.130]    [Pg.142]    [Pg.101]    [Pg.186]    [Pg.317]    [Pg.127]    [Pg.172]    [Pg.531]    [Pg.257]    [Pg.141]    [Pg.242]    [Pg.7]    [Pg.368]    [Pg.224]    [Pg.480]    [Pg.36]    [Pg.56]    [Pg.121]    [Pg.366]    [Pg.696]    [Pg.163]    [Pg.62]    [Pg.20]   
See also in sourсe #XX -- [ Pg.464 ]




SEARCH



Organometallic ruthenium -arene anticancer drugs

© 2024 chempedia.info